Advance
Article
|
X. Qiao, A. E. Zeitany, M. W. Wright, A. S. Essader, K. E. Levine, U. Bierbach: Analysis of the DNA damage produced by a platinum–acridine antitumor agent and its effects in NCI-H460 lung cancer cells. Metallomics (Advance Article). |
 |
L. Rao, J. D. Dworkin, W. E. Nell, U. Bierbach: Interactions of Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex. J. Phys. Chem. B, 115, 13701-13712. (2011) |
 |
C. L. Smyre, G. Saluta, T. E. Kute, G. L. Kucera, U. Bierbach: Inhibition of DNA Synthesis by a Platinum–Acridine Hybrid Agent Leads to Potent Cell Kill in Non-Small Cell Lung Cancer. ACS Medicinal Chemistry Letters, 2, 870-874. (2011) |
 |
H. Kostrhunova, J. Malina, A. J. Pickard, J. Stepankova, M. Vojtiskova, J. Kasparkova, T. Muchova, M. L. Rohlfing, U. Bierbach, V. Brabec: Replacement of a Thiourea with an Amidine Group in a Monofunctional Platinum–Acridine Antitumor Agent. Effect on DNA Interactions, DNA Adduct Recognition and Repair. Mol. Pharmaceutics, 8, 1941-1954. (2011) |
 |
L. A. Graham, G. M. Wilson, T. K. West, C. S. Day, G. L. Kucera, U. Bierbach: Unusual Reactivity of a Potent Platinum-Acridine Hybrid Antitumor Agent. ACS Medicinal Chemistry Letters, 2, 687-691. (2011) |
 |
J. R. Choudhury, L. Rao, U. Bierbach: Rates of intercalator-driven platination of DNA determined by restriction enzyme cleavage inhibition assay. Journal of Biological Inorganic Chemistry, 16, 373-380. (2011). |
 |
L. Rao, T. K. West, G. Saluta, G. L. Kucera, U. Bierbach: Probing Platinum-Adenine-N3 Adduct Formation with DNA Minor-Groove Binding Agents. Chemical Research in Toxicology, 23, 1148-1150. (2010). |
 |
L. C. Eiter, N. W. Hall, C. S. Day, G. Saluta, G. L. Kucera, U. Bierbach: Gold(I) Analogues of a Platinum-Acridine Antitumor Agent are Only Moderately Cytotoxic but Show Potent Activity against Mycobacterium tuberculosis. J. Med. Chem., 52, 6519-6522. (2009). |
 |
A. R. Kheradi, G. Saluta, G. L. Kucera, C. S. Day, U. Bierbach: Synthesis and biological evaluation of platinum-acridine hybrid agents modified with bipyridine non-leaving groups. Bioorg. Med. Chem. Lett., 19, 3423-3425. (2009). |
 |
Z. Ma, L. Rao, U. Bierbach: Replacement of a Thiourea-S with an Amidine-NH Donor Group in a Platinum-Acridine Antitumor Compound Reduces the Metal's Reactivity with Cysteine Sulfur. J. Med. Chem., 52, 3424-3427. (2009). |
 |
Z. Ma, J. Roy Choudhury, M. W. Wright, C. S. Day, G. Saluta, G. L. Kucera and U. Bierbach: A Non-Cross-Linking Platinum−Acridine Agent with Potent Activity in Non-Small-Cell Lung Cancer. J. Med. Chem., 51, 7574. (2008). |
 |
Z. Ma, G. Saluta, G. L. Kucera, and U. Bierbach: Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum–acridines. Bioorg. Med. Chem. Lett. 18, 3799. (2008). |
 |
J. Roy Choudhury, R.Guddneppanavar, G. Saluta, G. L. Kucera, and U. Bierbach: Tuning the DNA Conformational
Perturbations Induced by Cytotoxic Platinum−Acridine Bisintercalators: Effect of Metal Cis/Trans Isomerism and DNA Threading Groups. J. Med. Chem., 51, 3069. (2008). |
 |
L.Rao and U.Bierbach: Kinetically Favored Platination of Adenine in the G-Rich Human Telomeric Repeat. J. Am. Chem. Soc., 129, 15764. (2007). |
 |
Z. Ma, C. S. Day and U. Bierbach: Unexpected Reactivity of the 9-Aminoacridine Chromophore in Guanidylation Reactions. J. Org. Chem., 72, 5387. (2007). |
 |
A. L. Smith, C. S. Day, L. Que Jr., Y. Zhou and U. Bierbach: Unexpected assembly of a novel triply bridged diiron(II) core by a bidentate Schiff base ligand. Inorg. Chim. Acta., 360, 2824. (2007). |
 |
R. Guddneppanavar, J. R. Choudhury, A. R. Kheradi, B. D. Steen, G. Saluta, G. L. Kucera, C. S. Day, and U. Bierbach: Effect of the Diamine Nonleaving Group in Platinum-Acridinylthiourea Conjugates on DNA Damage and Cytotoxicity. J. Med. Chem., 50, 2259. (2007). |
 |
R. Guddneppanavar and U. Bierbach: Adenine-N3 in the DNA Minor Groove - An Emerging Target for Platinum Containing Anticancer Pharmacophores. Anti-Cancer Agents in Medicinal Chemistry, 7, 125. (2007). |
 |
R. Guddneppanavar, G. Saluta, G. L. Kucera, and U. Bierbach: Synthesis, Biological Activity, and DNA-Damage Profile of Platinum-Threading Intercalator Conjugates Designed To Target Adenine. J. Med. Chem., 49, 3204. (2006). |
 |
R. Guddneppanavar, M. W. Wright, A. K. Tomsey and U. Bierbach: Guanine Binding of a Cytotoxic Platinum-acridin-9-ylthiourea Conjugate Monitored by 1-D 1H and 2-D [1H, 15N] NMR Spectroscopy: Hydrolysis is not the Rate-determining Step. J. Inorg. Biochem. 100, 972. (2006). |
 |
J. Roy Choudhury, and U. Bierbach: Characterization of the Bisintercalative DNA Binding Mode of a Bifunctional Platinum -acridine Agent. Nucleic Acids Res. 33:5622 (2005). |
 |
Y. Ma, C. S. Day, and U. Bierbach: Synthesis, Structure, and Reactivity of Monofunctional Platinum(II) and Palladium(II) Complexes Containing the Sterically Hindered Ligand 6-(methylpyridin-2-yl)acetate. J. Inorg. Biochem., 99, 2013(2005). |
 |
M. E. Budiman, U. Bierbach, and R. W. Alexander: Minor Groove Adducts Formed by a Platinum-acridine Conjugate Inhibit Association of TATA-binding Protein with its Cognate Sequence. Biochem., 44, 11262 (2005). |
 |
S. M. Hess, A. M. Mounce, R. C. Sequeira, T. M. Augustus, M. C. Ackley, and U. Bierbach: Platinum-Acridinylthiourea Conjugates Show Cell Line Specific Cytotoxic Enhancement in H460 Lung Carcinoma Cells Compared to Cisplatin. Cancer Chemother. Pharmacol., 56,337 (2005). |
 |
H. Baruah, M. W. Wright, and U. Bierbach: Solution Structural Study of a DNA Duplex Containing the Guanine-N7 Adduct Formed by a Cytotoxic Platinum-Acridine Hybrid Agent. Biochemistry, 44, 6059-6070 (2005). |
 |
C. G. Barry, C. S. Day, and U. Bierbach: Duplex Promoted Platination of Adenine-N3 in the Minor Groove of DNA: Challenging a Longstanding Bioinorganic Paradigm. J. Am. Chem. Soc., 127, 1160-1169 (2005). |
 |
S. M. Hess, J. G. Anderson, and U. Bierbach: A Non-Crosslinking Platinum-Acridine Hybrid Agent Shows Enhanced Cytotoxicity Compared to Clinical BCNU and Cisplatin in Glioblastoma Cells. Bioorg. Med. Chem. Lett. 15, 443-446 (2005). |
 |
H. Baruah, C. G. Barry and U. Bierbach: Platinum-Intercalator Conjugates: From DNA-Targeted Cisplatin Derivatives to Adenine Binding Complexes as Potential Modulators of Gene Regulation. Curr. Topics Med. Chem. 4, 1537-1549 (2004). |
 |
M. E. Budiman, R. W. Alexander and U. Bierbach: Unique Base-Step Recognition by a Platinum-Acridinylthiourea Conjugate Leads to a DNA Damage Profile Complementary to That of the Anticancer Drug Cisplatin. Biochemistry 43, 8560-8567 (2004). |
 |
M. C. Ackley, C. G. Barry, A. M. Mounce, M. C. Farmer, B.-E. Springer, C. S. Day, M. W. Wright, S. J. Berners-Price, S. M. Hess, U. Bierbach: Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity. J. Biol. Inorg. Chem. 9, 453-461 (2004). |
 |
H. Baruah, C. S. Day, M. W. Wright and U. Bierbach: Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent. J. Am. Chem. Soc. 126, 4492-4493 (2004). |
|
H. Baruah and U. Bierbach: Biophysical characterization and molecular modeling of the coordinative-intercalative DNA monoadduct of a platinum-acridinylthiourea agent in a site-specifically modified dodecamer. J. Biol. Inorg. Chem. 9, 335-344 (2004). |
|
C. G. Barry, H. Baruah and U. Bierbach: Unprecedented Monofunctional Metalation of Adenine Nucleobase in Guanine and Thymine Containing Dinucleotide Sequences by a Cytotoxic Platinum-Acridine Hybrid Agent. J. Am. Chem. Soc. 125, 9629-9637 (2003). |
 |
H. Baruah and U. Bierbach: Unusual intercalation of acridin-9-ylthiourea into the 5'-GA/TC DNA base step from the minor groove: Implications for the covalent DNA adduct profile of a novel platinum-intercalator conjugate. Nucleic Acids Res. 31, 4138-4146 (2003). |
 |
T. M. Augustus, J. Anderson, S. M. Hess, and U. Bierbach: Bis(acridinylthiourea)platinum(II) Complexes: Synthesis, DNA Affinity, and Biological Activity in Glioblastoma Cells. Bioorg. Med. Chem. Lett. 13, 855-858 (2003). |
 |
C. G. Barry, E. C. Turney, C. S. Day, G. Saluta, G. L. Kucera, and U. Bierbach: Thermally Inert Metal Ammines as Light-inducible DNA-targeted Agents. Synthesis, Photochemistry, and Photobiology of a Prototypical Rhodium(III)-Intercalator Conjugate. Inorg. Chem., 41, 7159-7169 (2002). |
 |
J. M. Brow, C. R. Pleatman and U. Bierbach: Cytotoxic Acridinylthiourea and its Platinum Conjugate Produce Enzyme-mediated DNA Strand Breaks. Bioorg. Med. Chem. Lett., 12, 2953-2955 (2002). |
 |
H. Baruah, C.L. Rector, S. M. Monnier and U. Bierbach: Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. Biochem. Pharmacol., 64:191 (2002). |
 |
E. T. Martins, H. Baruah, J. Kramarczyk, G. Saluta, C. S. Day, G. L. Kucera and U. Bierbach: Design, synthesis and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore. J. Med. Chem., 44:4492 (2001). |
D. A. Sartori, B. Miller, U. Bierbach and N. Farrell: Modulation of the chemical and biological properties of transplatinum complexes. Monofunctional trans platinum complexes containing one nucleobase as potential antiviral chemotypes. J. Biol. Inorg. Chem., 5:575 (2000).
U. Bierbach, M. Sabat, and N. Farrell: Inversion of the cis-geometry requirement for cytotoxicity in novel platinum(II) complexes containing the bidentate N,O-donor pyridine-2-yl-acetate (PyAc). Inorg. Chem., 39:1882 (2000).
U. Bierbach, Y. Qu, T. W. Hambley, J. Peroutka, H. L. Nguyen, M. Doedee and N. Farrell: Synthesis, structure, biological activity, and DNA binding of platinum(II) complexes of the type trans-[PtCl2(NH3)L] (L = planar nitrogen base). Effect of L and cis/trans isomerism on sequence specificity and unwinding properties observed in globally platinated DNA. Inorg. Chem. 38:3535 (1999).
N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi and E. Menta: Structure-activity relationships within dinuclear and trinuclear platinum phase I clinical anticancer agents. In 30 Years of Cisplatin - Chemistry and Biochemistry of a Leading Anticancer Drug. B. Lippert, ed.; Verlag HCA, Basel, Switzerland, 1999.
U. Bierbach and N. Farrell: Structural and reactivity studies on the ternary system guanine/methionine/trans-[PtCl2(NH3)L)] (L = NH3, quinoline): Implications for the mechanism of action of nonclassical trans-platinum antitumor complexes. JBIC, 3:570 (1998).
A. Zákovscá, O. Nováková, Z. Balcarová, U. Bierbach, N. Farrell, and V. Brabec: DNA interactions of antitumor trans-[PtCl2(NH3)quinoline]. Eur. J. Biochem., 254:547 (1998).
U. Bierbach, T. W. Hambley and N. Farrell: Modification of Platinum(II) Antitumor Complexes with Sulfur Ligands. 1. Synthesis, Structure and Spectroscopic Properties of Cationic Complexes of the Types [PtCl(diamine)(L)]NO3 and [{PtCl(diamine)}2(L-L)](NO3)2 (L = Monofunctional Thiourea Derivative; L-L = Bifunctional Thiourea Derivative). Inorg. Chem. 37:708 (1998).
U. Bierbach, J. D. Roberts and N. Farrell: Modification of Platinum(II) Antitumor Complexes with Sulfur Ligands. 2. Reactivity and Nucleotide Binding Properties of Cationic Complexes of the Types [PtCl(diamine)(L)]NO3 and [{PtCl(diamine)}2(L-L)](NO3)2 (L = Monofunctional Thiourea Derivative; L-L = Bifunctional Thiourea Derivative) in Relation to Their Cytotoxicity. Inorg. Chem. 37:717 (1998).
U. Bierbach and N. Farrell: Modulation of Nucleotide Binding of Trans-Platinum Complexes by Planar Ligands. A Combined Proton NMR and Molecular Mechanics Study. Inorg. Chem. 36:3657 (1997).
U. Bierbach, T. W. Hambley, J. D. Roberts, and N. Farrell:Oxidative Addition of the Dithiobis(formamidinium) Cation to Platinum(II) Chloro Am(m)ine Compounds: Studies on Structure, Spectroscopic Properties, Reactivity and Cytotoxicity of a New Class of Platinum(IV) Complexes Exhibiting S-Thiourea Coordination. Inorg. Chem. 35:4865 (1996).
U. Bierbach and J. Reedijk:An Unusual Route to Potential Platinum Antitumor Compounds: Synthesis, Reactivity, and Spectroscopic Properties of the Pt(IV) Complex fac-[PtCl3(NH3)2L]Cl. Angew. Chem. Int. Ed. Engl. 33:1632 (1994).
N. Farrell and U. Bierbach: Water soluble transplatinum complexes with antitumor activity and method of using same. U.S. patent 6,001,872, Dec. 1999.
N. Farrell and U. Bierbach: Platinum complexes with anti-viral activity and method of using same. U.S. patent 6,113,934, Sep. 2000.
